Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis
Annals of Rheumatic Diseases Aug 24, 2017
Mantel A, et al. – The specialists attempted this work to evaluate long–term outcomes in patients with rheumatoid arthritis (RA) with acute coronary syndrome (ACS) compared with non–RA patients with ACS and to determine whether the use of secondary preventive drugs could explain any differences in ACS outcome. Findings revealed that following ACS, patients with RA suffer from an increased risk of ACS recurrence and of death. However, this could not be explained by differences in usage of secondary preventive drugs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries